Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|May 1, 2012
Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymeraseYaya Liu, Ben Hock Lim, Wen W Jiang, et al.Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazinesJohn K Pratt, Pamela Donner, Keith F McDaniel, et al.Bioorganic & Medicinal Chemistry Letters|May 7, 2013
Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5ADavid A DeGoey, David A Betebenner, David J Grampovnik, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2006
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ringTodd W Rockway, Rong Zhang, Dachun Liu, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2006
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamidesA Chris Krueger, Darold L Madigan, Wen W Jiang, et al.Bioorganic & Medicinal Chemistry Letters|February 16, 2007
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivativesA Chris Krueger, Darold L Madigan, Brian E Green, et al.Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivativesA Chris Krueger, Darold L Madigan, David W Beno, et al.Biochemistry|January 22, 2003
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor seriesVincent Stoll, Kent D Stewart, Clarence J Maring, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moietyDouglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.Journal of Medicinal Chemistry|June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitorsClarence J Maring, Vincent S Stoll, Chen Zhao, et al.Pageof 3